What is the current DNA/RNA Quality Control market size?

The DNA/RNA Quality Control market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the DNA/RNA Quality Control market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the DNA/RNA Quality Control market?

Increasing demand for genetic research and rising awareness of molecular diagnostics drive market growth.

What are the major challenges facing the DNA/RNA Quality Control market?

Stringent regulatory requirements and high costs of equipment hinder market expansion.

Which regions are leading the DNA/RNA Quality Control market?

North America and Europe are regional leaders, driven by strong research infrastructure.

Who are the top companies in the DNA/RNA Quality Control market?

Prominent players include Thermo Fisher, Agilent, and Illumina, offering innovative solutions.

What future opportunities exist in the DNA/RNA Quality Control market?

Emerging applications in precision medicine and gene editing present significant growth opportunities.

How is technology impacting the DNA/RNA Quality Control market?

Advances in sequencing technologies and automation enhance efficiency and accuracy.

What is the current regulatory landscape for the DNA/RNA Quality Control market?

Regulatory bodies like FDA and EU impose strict guidelines for quality control and assurance.

How will the DNA/RNA Quality Control market evolve in the next 5 years?

The market will witness significant growth, driven by increasing adoption of molecular diagnostics.

DNA/RNA Quality Control Market Comprehensive Report: 200+ Pages | 2026–2034

DNA/RNA Quality Control by Application (Biological Research, Medical Diagnostics, Genomics), by Types (DNA Quality Control, RNA Quality Control), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 140

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 140

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

DNA/RNA Quality Control Market Overview

The DNA/RNA Quality Control market is crucial for ensuring the accuracy and reliability of genetic research and testing. As the DNA/RNA Quality Control market size is expected to reach $1.8 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry. The market forecast for the DNA/RNA Quality Control market is anticipated to grow at a CAGR of 8.5% from 2026 to 2033, driven by increasing demand for high-quality genetic research and testing. The scope of the market encompasses various synonyms such as nucleic acid quality control, genetic material quality control, and molecular quality control.

Loading chart…

The DNA/RNA Quality Control market is being shaped by several key forces, including technology shifts towards automation and regulations governing genetic research. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific. The competitive intensity of the market is moderate, with major players competing for market share. The supply-chain dynamics are also crucial, with companies focusing on providing high-quality products and services to meet the increasing demand. Overall, the DNA/RNA Quality Control market is expected to experience significant industry expansion in the coming years, driven by the growing need for accurate and reliable genetic research and testing.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	QIMA Life Sciences; Thermo Fisher Scientific; QIAGEN; PathoQuest; Genomics; Cambridge Genomic Services; Eurofins Genomics; Creative Biogene; Norgen Biotek; Life Magnetics; BigOmics Analytics; LC Sciences; Omega Bioservices; Hokkaido System Science
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The DNA/RNA Quality Control market is witnessing significant growth, driven by increasing demand for high-quality DNA/RNA samples in research and diagnostic applications. The DNA/RNA Quality Control market size is expected to expand during the forecast period, driven by advancements in technology and growing investments in life sciences research.

Growth Drivers2 items

Advances in next-generation sequencing technologies are driving the need for high-quality DNA/RNA samples, thereby fueling the growth of the DNA/RNA Quality Control market.

Increasing regulatory requirements for DNA/RNA sample quality in clinical trials and diagnostic testing are also contributing to the market's growth forecast.

Restraints2 items

High costs associated with DNA/RNA quality control instruments and reagents are limiting the adoption of these products, particularly in resource-poor settings.

The lack of standardization in DNA/RNA quality control protocols is also hindering the growth of the DNA/RNA Quality Control market.

Opportunities2 items

The increasing demand for personalized medicine and precision diagnostics is creating new opportunities for DNA/RNA quality control companies to develop innovative products and services.

The growing biotechnology industry in emerging economies is also expected to drive the adoption of DNA/RNA quality control products, contributing to the DNA/RNA Quality Control market size.

Challenges2 items

The complexity of DNA/RNA quality control workflows and the need for specialized expertise are major challenges facing companies in this market.

The competitive landscape of the DNA/RNA Quality Control market is also highly fragmented, with many players competing for market share, which can make it difficult for companies to differentiate themselves and achieve growth forecast targets.

Market Segmentation

Loading chart…

The DNA/RNA Quality Control market can be segmented based on Application, which includes subtypes such as research and development, clinical diagnostics, and forensic analysis. Each of these subtypes contributes to the overall DNA/RNA Quality Control market size, with research and development being the largest segment. Understanding the DNA/RNA Quality Control segmentation is crucial for market players to identify opportunities and trends in the industry.

Another way to segment the DNA/RNA Quality Control market is by Types, which includes subtypes such as instruments, reagents and kits, and services. The instruments segment dominates the market, driven by the increasing demand for high-quality DNA/RNA analysis instruments. The reagents and kits segment is also expected to grow, driven by the rising adoption of DNA/RNA quality control products in research and clinical applications. The market taxonomy of the DNA/RNA Quality Control market reveals that each segment has its own unique characteristics and growth prospects.

DNA/RNA Quality Control Segmentation Breakdown7 items

Application

Biological Research

Medical Diagnostics

Genomics

Types

DNA Quality Control

RNA Quality Control

Regional Insights

Loading chart…

The DNA/RNA Quality Control market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of DNA/RNA quality control technologies in emerging countries.

Key drivers for each region include: for North America, investments in research and development, policies supporting genomics research, and a mature ecosystem. In Europe, drivers include adoption of quality control measures, demographics with an aging population, and infrastructure development. Asia Pacific is driven by investments in biotechnology, policies supporting innovation, and a growing ecosystem. Latin America and Middle East & Africa are driven by adoption of quality control measures, demographics with a growing population, and increasing infrastructure development.

The regional forecast indicates that the Asia Pacific region will experience the highest growth rate, driven by DNA/RNA quality control market growth in countries such as China and India. The Latin America and Middle East & Africa regions are expected to experience moderate growth, driven by increasing adoption of quality control measures and investments in research and development.

Competitive Landscape

The DNA/RNA Quality Control market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The DNA/RNA Quality Control competitive landscape is driven by companies that leverage these levers to differentiate themselves and gain market share. Global players tend to focus on product innovation and regulatory approvals, while local companies often emphasize distribution and pricing strategies.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. They also focus on competitive differentiation through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their market position.

QIMA Life Sciences: regional expansion

Thermo Fisher Scientific: innovation pipeline

QIAGEN: premium pricing

PathoQuest: OEM tie-ups

Genomics: local manufacturing

Cambridge Genomic Services: vertical integration

Key DNA/RNA Quality Control Companies14 items

QIMA Life Sciences

Thermo Fisher Scientific

QIAGEN

PathoQuest

Genomics

Cambridge Genomic Services

Eurofins Genomics

Creative Biogene

Norgen Biotek

Life Magnetics

BigOmics Analytics

LC Sciences

Omega Bioservices

Hokkaido System Science

Market Ecosystem

The DNA/RNA Quality Control ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem is characterized by a sequential flow of value creation, from raw material suppliers to manufacturers, and ultimately to channels and end users. The ecosystem boundaries are defined by the interactions among these participants, with value being created and captured at various stages, from research and development to commercialization and distribution.

Raw material suppliers — providing reagents and consumables

Technology providers — developing instrumentation and software

OEMs/manufacturers — producing DNA/RNA quality control products

System integrators/EPCs — integrating solutions for end users

Distributors/channel partners — delivering products to end users

Service providers/after-sales — offering maintenance and support

Regulators/standards bodies — establishing guidelines and standards

In the DNA/RNA Quality Control ecosystem, control points are largely influenced by regulators and standards bodies, as adherence to guidelines and standards is crucial for product adoption. Dependency risks arise from input constraints, such as the availability of raw materials, and approvals from regulatory bodies. Switching costs and partnerships are also significant, as end users often require customized solutions and may be locked into specific platforms. Furthermore, the ecosystem differs by region, with varying regulatory requirements and market needs. A thorough value chain analysis is essential to understanding the intricacies of the DNA/RNA Quality Control ecosystem and identifying opportunities for growth and innovation.

Recent Industry Insights

The DNA/RNA Quality Control industry trends have witnessed significant developments over the last 12-18 months. Notably, there has been a surge in partnerships between key players, with a focus on enhancing product offerings and expanding market reach. Recent mergers and acquisitions have also led to increased consolidation in the industry, resulting in more comprehensive solutions for customers. Furthermore, several product and technology launches have been observed, driven by advancements in sequencing technologies and the growing demand for high-quality DNA/RNA samples.

Additionally, regulatory changes have played a crucial role in shaping the industry, with a heightened emphasis on standardization and quality control. Shifts in consumer and enterprise trends have also been observed, with a growing preference for automated and high-throughput solutions. The industry has also seen notable funding rounds and expansions, underscoring the potential for growth and innovation in the DNA/RNA Quality Control industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the DNA/RNA Quality Control market outlook. The market attractiveness is high due to the increasing demand for high-quality DNA and RNA samples in research and diagnostic applications. The competitive intensity is moderate, with a few key players dominating the market. The long-term outlook is positive, driven by advancements in genetic research and the growing need for quality control measures.

The innovation landscape is evolving, with new technologies and products being developed to improve DNA and RNA quality control. The demand-supply balance is stable, with suppliers able to meet the current demand. However, key risk factors include regulatory changes and technological disruptions. Overall, the DNA/RNA Quality Control market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. DNA/RNA Quality Control Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global DNA/RNA Quality Control Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global DNA/RNA Quality Control Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biological Research

6.1.2. Medical Diagnostics

6.1.3. Genomics

6.2. Global DNA/RNA Quality Control Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. DNA Quality Control

6.2.2. RNA Quality Control

6.3. Global DNA/RNA Quality Control Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global DNA/RNA Quality Control Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global DNA/RNA Quality Control Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global DNA/RNA Quality Control Market Competition by Key Manufacturers

8.1. Global DNA/RNA Quality Control Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global DNA/RNA Quality Control: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. QIMA Life Sciences

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. QIAGEN

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. PathoQuest

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Genomics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cambridge Genomic Services

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Eurofins Genomics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Creative Biogene

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Norgen Biotek

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Life Magnetics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BigOmics Analytics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. LC Sciences

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Omega Bioservices

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Hokkaido System Science

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global DNA/RNA Quality Control Market

Figure 4: Global DNA/RNA Quality Control Market: Drivers

Figure 5: Global DNA/RNA Quality Control Market: Challenges

Figure 6: Global DNA/RNA Quality Control Market: Trends

Figure 7: Global DNA/RNA Quality Control Market: Opportunity

Figure 8: Global DNA/RNA Quality Control Market: Restraint

Figure 9: Global DNA/RNA Quality Control Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global DNA/RNA Quality Control Market Value (USD Million) By Region

Figure 15: Global DNA/RNA Quality Control Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global DNA/RNA Quality Control Market Value (USD Million) By Region

Figure 23: Global DNA/RNA Quality Control Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global DNA/RNA Quality Control Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global DNA/RNA Quality Control Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global DNA/RNA Quality Control Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global DNA/RNA Quality Control Market Value (USD Million) By Region

Table 10: Global DNA/RNA Quality Control Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global DNA/RNA Quality Control Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global DNA/RNA Quality Control Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global DNA/RNA Quality Control Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: QIMA Life Sciences Basic Information And Sales Area

Table 31: QIMA Life Sciences. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: QIAGEN Basic Information And Sales Area

Table 35: QIAGEN. Products Portfolio

Table 36: PathoQuest Basic Information And Sales Area

Table 37: PathoQuest. Products Portfolio

Table 38: Genomics Basic Information And Sales Area

Table 39: Genomics. Products Portfolio

Table 40: Cambridge Genomic Services Basic Information And Sales Area

Table 41: Cambridge Genomic Services. Products Portfolio

Table 42: Eurofins Genomics Basic Information And Sales Area

Table 43: Eurofins Genomics. Products Portfolio

Table 44: Creative Biogene Basic Information And Sales Area

Table 45: Creative Biogene. Products Portfolio

Table 46: Norgen Biotek Basic Information And Sales Area

Table 47: Norgen Biotek. Products Portfolio

Table 48: Life Magnetics Basic Information And Sales Area

Table 49: Life Magnetics. Products Portfolio

Table 50: BigOmics Analytics Basic Information And Sales Area

Table 51: BigOmics Analytics. Products Portfolio

Table 52: LC Sciences Basic Information And Sales Area

Table 53: LC Sciences. Products Portfolio

Table 54: Omega Bioservices Basic Information And Sales Area

Table 55: Omega Bioservices. Products Portfolio

Table 56: Hokkaido System Science Basic Information And Sales Area

Table 57: Hokkaido System Science. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global DNA/RNA Quality Control Market Value (USD Million) By Region

Table 63: Global DNA/RNA Quality Control Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

DNA/RNA Quality Control Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	QIMA Life Sciences; Thermo Fisher Scientific; QIAGEN; PathoQuest; Genomics; Cambridge Genomic Services; Eurofins Genomics; Creative Biogene; Norgen Biotek; Life Magnetics; BigOmics Analytics; LC Sciences; Omega Bioservices; Hokkaido System Science
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in next-generation sequencing technologies are driving the need for high-quality DNA/RNA samples, thereby fueling the growth of the DNA/RNA Quality Control market.

Increasing regulatory requirements for DNA/RNA sample quality in clinical trials and diagnostic testing are also contributing to the market's growth forecast.

Restraints2 items

High costs associated with DNA/RNA quality control instruments and reagents are limiting the adoption of these products, particularly in resource-poor settings.

The lack of standardization in DNA/RNA quality control protocols is also hindering the growth of the DNA/RNA Quality Control market.

Opportunities2 items

The increasing demand for personalized medicine and precision diagnostics is creating new opportunities for DNA/RNA quality control companies to develop innovative products and services.

The growing biotechnology industry in emerging economies is also expected to drive the adoption of DNA/RNA quality control products, contributing to the DNA/RNA Quality Control market size.

Challenges2 items

The complexity of DNA/RNA quality control workflows and the need for specialized expertise are major challenges facing companies in this market.

Market Segmentation

Loading chart…

DNA/RNA Quality Control Segmentation Breakdown7 items

Application

Biological Research

Medical Diagnostics

Genomics

Types

DNA Quality Control

RNA Quality Control

Regional Insights

Loading chart…

Competitive Landscape

QIMA Life Sciences: regional expansion

Thermo Fisher Scientific: innovation pipeline

QIAGEN: premium pricing

PathoQuest: OEM tie-ups

Genomics: local manufacturing

Cambridge Genomic Services: vertical integration

Key DNA/RNA Quality Control Companies14 items

QIMA Life Sciences

Thermo Fisher Scientific

QIAGEN

PathoQuest

Genomics

Cambridge Genomic Services

Eurofins Genomics

Creative Biogene

Norgen Biotek

Life Magnetics

BigOmics Analytics

LC Sciences

Omega Bioservices

Hokkaido System Science

Market Ecosystem

Raw material suppliers — providing reagents and consumables

Technology providers — developing instrumentation and software

OEMs/manufacturers — producing DNA/RNA quality control products

System integrators/EPCs — integrating solutions for end users

Distributors/channel partners — delivering products to end users

Service providers/after-sales — offering maintenance and support

Regulators/standards bodies — establishing guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents